NEXGEL, INC.NXGLEarnings & Financial Report
NEXGEL, INC. is a specialty consumer healthcare and medical technology firm that develops, manufactures and distributes ultra-gentle, irritation-free hydrogel products. Its offerings span over-the-counter skincare remedies, wound care solutions, and topical drug delivery platforms, serving consumer, clinical and pharmaceutical partner segments primarily across North America, with growing global distribution channels.
Revenue
$2.9M
Gross Profit
$1.3M
Operating Profit
$-636.0K
Net Profit
$-665.0K
Gross Margin
43.6%
Operating Margin
-22.1%
Net Margin
-23.1%
YoY Growth
100.3%
EPS
$-0.09
NEXGEL, INC. Q2 FY2025 Financial Summary
NEXGEL, INC. reported revenue of $2.9M (up 100.3% YoY) for Q2 FY2025, with a net profit of $-665.0K (up 24.9% YoY) (-23.1% margin). Cost of goods sold was $1.6M, operating expenses totaled $1.9M.
Key Financial Metrics
| Total Revenue | $2.9M |
|---|---|
| Net Profit | $-665.0K |
| Gross Margin | 43.6% |
| Operating Margin | -22.1% |
| Report Period | Q2 FY2025 |
Revenue Breakdown
NEXGEL, INC. Q2 FY2025 revenue of $2.9M breaks down across 2 segments, led by Branded Consumer Products at $1.9M (65.3% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Branded Consumer Products | $1.9M | 65.3% |
| Other | $1.0M | 34.7% |
NEXGEL, INC. Revenue by Segment — Quarterly Trend
NEXGEL, INC. revenue by segment across the last 4 reported quarters, showing how each business line (such as Branded Consumer Products and Other) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Branded Consumer Products | — | $1.9M | $1.9M | — |
| Other | — | $1.0M | $1.0M | — |
NEXGEL, INC. Annual Revenue by Year
NEXGEL, INC. annual revenue history includes year-by-year totals (for example, 2025 revenue was $11.4M).
| Year | Annual Revenue |
|---|---|
| 2025 | $11.4M |
| 2024 | $8.7M |
| 2023 | $4.1M |
| 2022 | $2.0M |
NEXGEL, INC. Quarterly Revenue & Net Profit History
NEXGEL, INC. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $2.8M | -8.1% | $-970.0K | -34.7% |
| Q3 FY2025 | $2.9M | -0.2% | $-653.0K | -22.3% |
| Q2 FY2025 | $2.9M | +100.3% | $-665.0K | -23.1% |
| Q1 FY2025 | $2.8M | +121.6% | $-712.0K | -25.4% |
| Q4 FY2024 | $3.0M | +181.4% | $-850.0K | -27.9% |
| Q3 FY2024 | $2.9M | +140.8% | $-693.0K | -23.6% |
| Q2 FY2024 | $1.4M | +23.4% | $-885.0K | -61.5% |
| Q1 FY2024 | $1.3M | +104.2% | $-853.0K | -67.4% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3M | $1.4M | $2.9M | $3.0M | $2.8M | $2.9M | $2.9M | $2.8M |
| YoY Growth | 104.2% | 23.4% | 140.8% | 181.4% | 121.6% | 100.3% | -0.2% | -8.1% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $10.4M | $9.8M | $10.6M | $11.0M | $10.4M | $9.7M | $11.6M | $10.5M |
| Liabilities | $5.2M | $5.2M | $5.6M | $4.9M | $4.9M | $4.7M | $6.0M | $5.6M |
| Equity | $4.8M | $4.2M | $4.7M | $5.8M | $5.2M | $4.7M | $5.2M | $4.5M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-1.1M | $-700000 | $-1.2M | $-859000 | $-400000 | $-407000 | $-785000 | $281000 |